TNF-α单克隆抗体对变应性鼻炎小鼠自噬水平影响的实验研究
该研究将30只6周龄雌性BALB/c小鼠随机分为5组,每组6只,建立变应性鼻炎模型后给予TNF-α单克隆抗体、自噬抑制剂3-MA或自噬诱导剂雷帕霉素干预,检测行为学、鼻黏膜病理、血清炎症因子及自噬相关指标。结果显示TNF-α抗体与3-MA均减轻AR症状并降低自噬水平,而雷帕霉素可拮抗TNF-α抗体的治疗作用,提示TNF-α单克隆抗体通过抑制自噬改善AR小鼠鼻部症状。
要点
- TNF-α单克隆抗体可减轻AR小鼠鼻部症状及鼻黏膜病理改变。
- TNF-α抗体降低血清IgE、TNF-α、IL-4、IFN-γ并下调鼻黏膜自噬水平。
- 自噬诱导剂雷帕霉素可拮抗TNF-α单克隆抗体对AR的治疗作用。
核心结论
- TNF-α单克隆抗体可抑制自噬水平,显著改善AR小鼠鼻部症状。
研究设计与样本
- 30只6周龄雌性BALB/c小鼠按随机数字表法分为对照组、AR组、AR+TNF-α组、AR+3-MA组、AR+TNF-α+RAP组,每组6只。
- 常规方法建立AR模型,于鼻腔激发致敏前给予相应试剂并持续整个实验过程。
- 检测行为学评分、鼻黏膜HE染色病理、血清炎症因子及IgE,并用实时定量PCR、蛋白印迹法和免疫荧光检测自噬相关指标。
主要发现
- 与AR组比较,AR+TNF-α组及AR+3-MA组小鼠AR症状较轻、鼻黏膜病理学变化较弱。
- AR+TNF-α组及AR+3-MA组血清IgE、TNF-α、IL-4、IFN-γ表达显著减少,P值均<0.05。
- AR+TNF-α组及AR+3-MA组鼻黏膜LC3B Ⅱ/Ⅰ、Beclin-1、ATG5、ATG7表达明显降低,p62表达明显升高。
- 采用自噬诱导剂RAP干预后,TNF-α单克隆抗体对AR的治疗作用被拮抗。
关键数值与推荐
- 血清TNF-α:AR+TNF-α组112.06±12.95、AR+3-MA组113.17±15.43、AR组161.22±17.96(x±s)。
- 血清IL-4:AR+TNF-α组54.05±7.14、AR+3-MA组58.26±5.67、AR组79.95±6.33(x±s)。
- 血清IFN-γ:AR+TNF-α组28.58±4.51、AR+3-MA组30.67±2.60、AR组39.83±3.31(x±s)。
临床怎么用
- 动物实验提示TNF-α单克隆抗体可能通过抑制自噬减轻AR炎症反应,为AR靶向治疗提供实验依据。
- 自噬通路可能是TNF-α抗体治疗AR的作用环节,联合自噬诱导剂可能削弱其疗效。
局限性
- 研究为小鼠实验,样本量每组6只,结果尚不能直接推及临床人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To observe the effect of tumor necrosis factor-α (TNF-α) monoclonal antibody on autophagy in allergic rhinitis (AR) mice. Methods: Thirty six weeks old BALB/c mice were randomly divided by random number table method into five groups: control group, model group (AR group), TNF-α antibody intervention group (AR+TNF-α group), autophagy inhibitor (3-methylindole, 3-NA) intervention group (AR+3-MA group), TNF-α antibody combined with autophagy inducer rapamycin (RAP) intervention group (AR+TNF-α+RAP group), with 6 mice in each group. AR model was established by conventional method, the corresponding reagent was administered before nasal cavity stimulation sensitization and during the whole experiment. Behavioral scores of mice were obtained, blood was collected from the eye socket, and mice in each group were sacrificed to collect nasal mucosa tissue samples. Pathological changes of nasal mucosa were observed by hematoxylin-eosin staining. Expression levels of inflammatory factor and IgE in serum were detected by enzyme-linked immunosorbent assay (ELISA). Expressions of autophagy related indicators microtubule-associated protein-1 light chain-3B (LC3B), Beclin-1, sequestosome1 (p62), autophagy-related 5 (ATG5), autophagy-related 7 (ATG7) were measured by Real-time PCR and Western blot. The aggregation of LC3B protein was observed by immunofluorescence. SPSS 19.0 software was used for statistical analysis. Results: Compared with the AR model group, symptoms of AR in AR+TNF-α group and AR+3-MA group were mild; the pathological changes of nasal mucosa were weak; the expression of IgE, TNF-α, interleukin 4 (IL-4), interferon-γ (IFN-γ) in serum significantly reduced (IgE: 666.19±78.35 (x±s) vs. 692.38±64.29 vs. 1 059.05±146.44, TNF-α: 112.06±12.95 vs. 113.17±15.43 vs. 161.22±17.96, IL-4: 54.05±7.14 vs. 58.26±5.67 vs. 79.95±6.33, IFN-γ: 28.58±4.51 vs. 30.67±2.60 vs. 39.83±3.31, all P<0.05), and the expression of LC3B Ⅱ/Ⅰ, Beclin-1, ATG5, ATG7 in nasal mucosa significantly decreased, the expression of p62 significantly elevated. After intervention with autophagy inducer RAP, the therapeutic effect of TNF-α monoclonal antibodies on AR was antagonized. Conclusion: TNF-α monoclonal antibody significantly improves nasal symptoms in AR mice by inhibiting autophagy levels. 目的: 观察肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)单克隆抗体对变应性鼻炎(allergic rhinitis,AR)模型小鼠自噬的影响。 方法: 30只6周龄雌性BALB/c小鼠,随机数字表法分为对照组、模型组(即AR组)、TNF-α抗体干预组(即AR+TNF-α组)、自噬抑制剂3-甲基嘌呤(3-methylindole, 3-MA)干预组(即AR+3-MA组)、TNF-α抗体联合自噬诱导剂雷帕霉素(rapamycin, RAP)干预组(即AR+TNF-α+RAP组)5个组,每组6只。常规方法制作AR模型,于鼻腔激发致敏前给予相应试剂,并持续整个实验过程。对小鼠进行行为学评分,眼窝静脉采血,处死小鼠收集鼻黏膜组织,苏木精-伊红染色观察鼻黏膜病理学变化,酶联免疫吸附测定法检测血清中炎性因子及IgE的表达,实时定量聚合酶链反应结合蛋白印迹法检测自噬相关指标微管相关蛋白1轻链3B(microtubule-associated protein-1 light chain-3B,LC3B)、Beclin-1、死骨片重组蛋白1(sequestosome1,p62)、自噬相关基因5(autophagy-related 5,ATG5)、自噬相关基因7(autophagy-related 7,ATG7)的表达,免疫荧光观察LC3B蛋白点状聚集情况。应用SPSS 19.0软件进行统计学分析。 结果: 同AR组比较,AR+TNF-α及AR+3-MA组小鼠AR症状较轻;鼻黏膜病理学变化较弱;血清IgE、TNF-α、白细胞介素4(interleukin 4,IL-4)、γ干扰素(interferon-γ,IFN-γ)的表达显著减少[IgE:666.19±78.35(x±s,下同)比692.38±64.29比1 059.05±146.44,TNF-α:112.06±12.95比113.17±15.43比161.22±17.96,IL-4∶54.05±7.14比58.26±5.67比79.95±6.33,IFN-γ:28.58±4.51比30.67±2.60比39.83±3.31,P值均<0.05];鼻黏膜组织中LC3B Ⅱ/Ⅰ、Beclin-1、ATG5、ATG7的表达明显降低,p62的表达明显升高。采用自噬诱导剂RAP干预后,TNF-α单克隆抗体对AR的治疗作用被拮抗。 结论: TNF-α单克隆抗体可抑制自噬水平,显著改善AR小鼠鼻部症状。.
引用
- Zhang S, Yan ZY, Wang D, et al. [Experimental study on the effects of tumor necrosis factor-α monoclonal antibody on autophagy level in allergic rhinitis mice]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31315359. doi:10.3760/cma.j.issn.1673-0860.2019.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。